Description
TRI ITRA Powder is an innovative pharmaceutical product that combines Itraconazole B.P. 130mg with state-of-the-art SUBA Technology. Designed to enhance the bioavailability of poorly soluble drugs, this powder formulation utilizes a solid dispersion of the drug in a polymer matrix. This unique approach significantly improves the dissolution of Itraconazole compared to its conventional crystalline form, ensuring better absorption and therapeutic effectiveness.
Key Features:
- Enhanced Bioavailability: The advanced SUBA Technology optimizes the drug’s solubility, allowing for faster and more efficient absorption in the body.
- Therapeutic Equivalence: Each 130mg dose of TRI ITRA Powder is therapeutically equivalent to a 100mg capsule of conventional Itraconazole, providing effective dosing flexibility.
- Broad Spectrum Activity: TRI ITRA Powder is effective against a wide range of fungal infections, making it a preferred choice for patients requiring robust antifungal treatment.
- Better Compliance and Acceptance: The formulation is designed for improved patient compliance compared to traditional treatments like Fluconazole, ensuring better adherence to therapy.
Indications: TRI ITRA Powder is indicated for the treatment of various fungal infections, including:
- Onychomycosis
- Tinea corporis
- Tinea cruris
- Tinea pedis
Recommended Use: For optimal results, follow the dosage and administration guidelines provided by a healthcare professional. TRI ITRA Powder can be reconstituted as directed and is suitable for patients who may have difficulty swallowing capsules or tablets.
With TRI ITRA Powder, experience the benefits of cutting-edge pharmaceutical technology for effective and reliable antifungal treatment.